Vivos Therapeutics, Inc.

Nasdaq:VVOS

Surgical & Medical Instruments & Apparatus·LITTLETON, CO

CEO

Huntsman Ronald Kirk

CFO

Amman Bradford K.

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/19/25	→
10-Q	Q2 2025	6/30/25	8/19/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
11/19/25	Q4 FY2025	→
8/20/25	Q3 FY2025	→
5/15/25	Q2 FY2025	→
3/31/25	Q1 FY2025	→
11/14/24	Q4 FY2024	→
8/15/24	Q3 FY2024	→
↓

News (8-K)

51 shown

Filed	Type	Description
2/6/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/20/26	Agreement	Entry into a Material Definitive Agreement	→
1/16/26	Agreement	Entry into a Material Definitive Agreement	→
12/17/25	Other	Other Events	→
12/5/25	Agreement	Entry into a Material Definitive Agreement	→
11/4/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

37 shown

Filed	Form	Description
2/17/26	S-3	S-3	→
1/14/26	424B3	424B3	→
10/24/25	424B5	424B5	→
9/12/25	424B5	424B5	→
9/5/25	S-3/A	S-3/A	→
2/14/25	424B5	424B5	→
↓

Filing History(253 filings)

TypeDateAccessionPeriodSize

S-3

Feb 17, 2026

0001493152-26-006829S-3

—

574.8 KB

Feb 13, 2026

0001493152-26-0068353

Feb 4, 2026

3.7 KB

8-K

Feb 6, 2026

0001493152-26-0055548-K

Feb 6, 2026

199.1 KB

8-K

Jan 20, 2026

0001493152-26-0028448-K

Jan 20, 2026

732.2 KB

8-K

Jan 16, 2026

0001493152-26-0025578-K

Jan 16, 2026

253.4 KB

424B3

Jan 14, 2026

0001493152-26-002251424B3

—

316.5 KB

EFFECT

Jan 7, 2026

9999999995-26-000088

—

1.9 KB

POS AM

Jan 2, 2026

0001493152-26-000155POS AM

—

595.5 KB

8-K

Dec 17, 2025

0001493152-25-0280198-K

Dec 16, 2025

221.7 KB

8-K

Dec 5, 2025

0001493152-25-0264388-K

Dec 5, 2025

503.2 KB

8-K

Nov 19, 2025

0001493152-25-0242898-K

Nov 19, 2025

299.8 KB

10-Q

Nov 19, 2025

0001493152-25-02425310-Q

Sep 30, 2025

6.2 MB

NT 10-Q

Nov 14, 2025

0001493152-25-023404NT 10-Q

Sep 30, 2025

32.2 KB

8-K

Nov 4, 2025

0001493152-25-0207508-K

Nov 4, 2025

210.2 KB

424B5

Oct 24, 2025

0001493152-25-019362424B5

—

16.6 KB

8-K

Oct 24, 2025

0001493152-25-0193598-K

Oct 24, 2025

218.4 KB

DEF 14A

Sep 29, 2025

0001493152-25-015837DEF 14A

Sep 26, 2025

8.4 MB

8-K

Sep 18, 2025

0001493152-25-0139538-K

Sep 17, 2025

233.3 KB

8-K

Sep 12, 2025

0001641172-25-0272108-K

Sep 12, 2025

478.9 KB

424B5

Sep 12, 2025

0001641172-25-027207424B5

—

581.3 KB

EFFECT

Sep 10, 2025

9999999995-25-002902

—

1.9 KB

CORRESP

Sep 8, 2025

0001641172-25-026884

—

11.0 KB

S-3/A

Sep 5, 2025

0001641172-25-026733S-3/A

—

405.9 KB

8-K/A

Aug 25, 2025

0001641172-25-0253968-K/A

Jun 9, 2025

896.9 KB

8-K

Aug 20, 2025

0001641172-25-0249798-K

Aug 20, 2025

292.1 KB

25 filings shown

Vivos Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(253 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
9/29/25	DEF 14A	DEF 14A	→
11/6/24	DEFA14A	DEFA14A	→
10/7/24	DEF 14A	DEF 14A	→
9/14/23	DEFA14A	DEFA14A	→
9/6/23	DEFA14A	DEFA14A	→
8/28/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
2/13/26	3	3	→
6/20/25	3	PRIMARY DOCUMENT	→
11/27/24	4	4	→
11/27/24	4	4	→
11/14/24	SC 13G/A	SC 13G/A	→
11/14/24	SC 13G/A	SC 13G/A	→
↓

Filed	Form	Description
1/7/26	EFFECT	EFFECT	→
1/2/26	POS AM	POS AM	→
9/10/25	EFFECT	EFFECT	→
7/14/25	SCHEDULE 13G	SCHEDULE 13G	→
6/16/25	SCHEDULE 13D	SCHEDULE 13D	→
1/30/25	EFFECT	EFFECT	→
↓